These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 38755125)

  • 1. Immunometabolism in cancer: basic mechanisms and new targeting strategy.
    Su R; Shao Y; Huang M; Liu D; Yu H; Qiu Y
    Cell Death Discov; 2024 May; 10(1):236. PubMed ID: 38755125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic nexus of T cell immunometabolism in improving transplantation immunotherapy.
    Kazmi S; Khan MA; Shamma T; Altuhami A; Assiri AM; Broering DC
    Int Immunopharmacol; 2022 May; 106():108621. PubMed ID: 35189469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.
    Mafi S; Mansoori B; Taeb S; Sadeghi H; Abbasi R; Cho WC; Rostamzadeh D
    Front Immunol; 2021; 12():774103. PubMed ID: 35250965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.
    Bandi DSR; Sarvesh S; Farran B; Nagaraju GP; El-Rayes BF
    Cytokine Growth Factor Rev; 2023; 71-72():26-39. PubMed ID: 37407355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunometabolism shapes B cell fate and functions.
    Fu Y; Wang L; Yu B; Xu D; Chu Y
    Immunology; 2022 Aug; 166(4):444-457. PubMed ID: 35569110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy.
    Chen S; Duan H; Sun G
    Biomed Pharmacother; 2023 Aug; 164():114963. PubMed ID: 37269814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression.
    Flati I; Di Vito Nolfi M; Dall'Aglio F; Vecchiotti D; Verzella D; Alesse E; Capece D; Zazzeroni F
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR-dependent immunometabolism as Achilles' heel of anticancer therapy.
    Braun C; Weichhart T
    Eur J Immunol; 2021 Dec; 51(12):3161-3175. PubMed ID: 34648202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses.
    Huldani H; Malviya J; Rodrigues P; Hjazi A; Deorari MM; Al-Hetty HRAK; Qasim QA; Alasheqi MQ; Ihsan A
    Cell Biochem Funct; 2024 Mar; 42(2):e3934. PubMed ID: 38379261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.
    Mockler MB; Conroy MJ; Lysaght J
    Front Oncol; 2014; 4():107. PubMed ID: 24904823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intracellular innate immune receptors on immunometabolism.
    Chou WC; Rampanelli E; Li X; Ting JP
    Cell Mol Immunol; 2022 Mar; 19(3):337-351. PubMed ID: 34697412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inosine, gut microbiota, and cancer immunometabolism.
    Samami E; Aleebrahim-Dehkordi E; Mohebalizadeh M; Yaribash S; Saghazadeh A; Rezaei N
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E1-E8. PubMed ID: 36416582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.
    Riera-Domingo C; Audigé A; Granja S; Cheng WC; Ho PC; Baltazar F; Stockmann C; Mazzone M
    Physiol Rev; 2020 Jan; 100(1):1-102. PubMed ID: 31414610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
    Sheppard AD; Lysaght J
    Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
    Lim AR; Rathmell WK; Rathmell JC
    Elife; 2020 May; 9():. PubMed ID: 32367803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment.
    Zhu Z; Parikh P; Zhao H; Givens NT; Beck DB; Willson CM; Bai Q; Wakefield MR; Fang Y
    Cancer Lett; 2021 Oct; 518():94-101. PubMed ID: 34153401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic interventions: A new insight into the cancer immunotherapy.
    Yu T; Dong T; Eyvani H; Fang Y; Wang X; Zhang X; Lu X
    Arch Biochem Biophys; 2021 Jan; 697():108659. PubMed ID: 33144083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.